In this study, we hypothesized that (1) elevated FGF23 levels in critically-ill patients is associated with severe AKI and (2) FGF23 association with severe AKI is mediated, at least in part, by endothelium-related biomarkers. This evidence concerns the gene FGF23 and acute kidney injury.